Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ISU
Seongnam-si, Gyeonggi-do, South Korea
- Ownership
- Private
- Employees
- ~160
- Development stage
- Other
01
Overview
ISU ABXIS is a South Korean biotechnology company specializing in the development of therapeutic antibodies and orphan drugs for rare diseases. Founded in 2001 as a subsidiary of the ISU Group, the company has successfully commercialized several products, including enzyme replacement therapies for Fabry disease and Gaucher disease. Their pipeline includes innovative antibody candidates targeting ErbB3 for oncology and biosimilars for hematological conditions. ISU ABXIS leverages its proprietary antibody platform to advance treatments from discovery through clinical development and global commercialization. The company is publicly traded on the KOSDAQ and maintains strategic partnerships to expand its international reach.
- Therapeutic areas
- HematologyCardiovascularOncologyRare Diseases
- Modalities
- Monoclonal antibodyRecombinant proteinEnzyme replacement therapyMonoclonal antibody fragment
- Industry
- Biotech
02
Partnerships
Catalyst BiosciencesPharmascienceLuye Pharma
Beyond the preview
Go deeper on ISU.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ISU.